- Mozart Therapeutics, a Seattle-based biotech startup, raised $55m funding. - The round was led by ARCH Venture Partners along with Sofinnova Partners. - Other backers include MRL Ventures Fund from Merck, Leaps by Bayer, and Eli Lilly & Company.

– Tissium is a medtech company developing biomorphic programmable polymers for tissue reconstruction.
– Company raised €50M in Series C financing.
– The round was led by Cathay Health, affiliated to global investment firm Cathay Capital, with participation from existing shareholders Sofinnova Partners, and others.
– The company intends to use the funds to continue to execute on its development plan, up to the commercialization of its nerve repair, hernia repair and cardiovascular sealant products.

– Protera, an AI-driven startup designing and developing new proteins to enable a wide range of natural and sustainable solutions, announced the final close of its Series A financing, at $10 million.
– The round was led by Sofinnova Partners, a leading European life sciences venture capital firm specialized in healthcare and sustainability.
– Protera is currently scaling-up its manufacturing process and validating its protein-based ingredients with several multinational companies.
– In particular, the financing will fast-track the scale up of protera guard™, a protein that extends the shelf-life of foods and replaces widely used chemical ingredients, with an efficient natural alternative.

– Comet Bio from London, Ontario CA- and Schaumburg, Illinois-based food technology company raised $22M in Series C funding.
– The round was led by Open Prairie with participation from Louis Dreyfus Company (LDC), BDC Capital, Sofinnova Partners.
– The new investment will be used to meet the market demand for its ingredients.

– Muna Therapeutics from Copenhagen develops small molecule programs focused on repairing neuronal dysfunction, resolving neuroinflammation and restoring neuroprotection and resilience to disease.
– The company raised $73m in Series A funding.
– The round was led by Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund with participation from Polaris Partners, Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures and VIB.
– The company intends to use the funds to advance its programs to IND applications.

– Micropep is a Toulouse, France-based agricultural biotech company.
– The company raised €8.5M in Series A funding.
– The round was led by Supernova Invest with participation from FMC Ventures, Sofinnova Partners and IRDI Capital Investissement.
– The new financing will be used to further develop proprietary discovery platform and progress pipeline targeting disease control and weed suppression.

– Mnemo Therapeutics completed its €75m Series A financing.
– The round was led by Casdin Capital, returning investor Sofinnova Partners, and an undisclosed investor, including participation from Redmile, Emerson Collective and Alexandria Venture Investments.
– The Series A financing will allow the company to accelerate development of the EnfiniT targeting and next generation chimeric antigen receptors (CAR) T cell therapy platform combining the pioneering research from Institut Curie and Memorial Sloan Kettering Cancer Center (MSK).

– Mainstay Medical Holdings, a Dublin, Ireland-based medical device company focused on commercializing an innovative implantable restorative neurostimulation system for people with disabling mechanical Chronic Low Back Pain, closed an equity financing of US$108m.
– The round was co-led by new investors Ally Bridge Group and Sofinnova Partners, through its Crossover Fund, and also included a large, global medical device company.
– Key existing investors participating include Sofinnova Partners (Capital Fund), KCK Group and Fountain Healthcare Partners.